Dextech Medical AB (DEXTECH)

Currency in SEK
9.900
+0.040(+0.41%)
Closed·
Advertisement
DEXTECH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9.9009.900
52 wk Range
5.85014.400
Key Statistics
Bid/Ask
9.40 / 9.76
Prev. Close
9.9
Open
9.9
Day's Range
9.9-9.9
52 wk Range
5.85-14.4
Volume
830
Average Volume (3m)
3.99K
1-Year Change
11.236%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DEXTECH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell

Earnings

Latest Release
31/08/2026
EPS / Forecast
-0.10 / --
Revenue / Forecast
1.45M / --
EPS Revisions
Last 90 days

Compare DEXTECH to Peers and Sector

Metrics to compare
DEXTECH
Peers
Sector
Relationship
P/E Ratio
−28.3x15.0x−0.4x
PEG Ratio
0.82−0.300.00
Price/Book
10.0x3.4x2.6x
Price / LTM Sales
44.1x13.2x3.0x
Upside (Analyst Target)
-175.4%54.5%
Fair Value Upside
Unlock5.2%7.2%Unlock

Dextech Medical AB engages in the development of drug candidates with application in urological oncology, primarily prostate cancer in Sweden. The company’s lead candidate, OsteoDex, which has completed a phase IIb clinical trial for the treatment of bone metastases in castration-resistant prostate cancer, as well as in preclinical stage to treat breast and lung cancer, as well as multiple myeloma. The company is also developing SomaDex, a medication candidate that is based on an endogenous hormone, somatostatin, or the treatment of acromegaly, neuroendocrine tumors, and palliative care in advanced prostate cancer; and PSMA-binding conjugates for the target-specific treatment of mCRPC that overexpresses prostate specific membrane antigen (PSMA). In addition, the company offers GuaDex (formarly CatDex), a technology platform and a charge-modified dextran molecule with tumor-toxic properties used for medication development. Dextech Medical AB was incorporated in 2004 and is based in Uppsala, Sweden.

FAQ

What Is the Dextech Medical (Spotlight: DEXTECH) Share Price Today?

The Dextech Medical stock price today is 9.900 SEK.

What Stock Exchange Does Dextech Medical (DEXTECH) Trade On?

Dextech Medical is listed and trades on the Spotlight Stock Market.

What Is the Ticker (Stock Symbol) for Dextech Medical?

The stock symbol (also called a 'ticker') for Dextech Medical is "DEXTECH."

What Is the Current Dextech Medical Market Capitalisation?

As of today, Dextech Medical (Spotlight: DEXTECH) market cap is 183.010M SEK.

What Is Dextech Medical's (DEXTECH) Earnings Per Share (TTM)?

The Dextech Medical EPS is currently -0.350 (Trailing Twelve Months).

Is DEXTECH a Buy or Sell From a Technical Analyst Perspective?

Based on today's Dextech Medical moving averages and other technical indicators, the daily buy/sell signal for DEXTECH stock is Strong Sell.

How Many Times Has Dextech Medical Stock Split?

Dextech Medical has split 2 times. (See the DEXTECH stock split history page for full effective split date and price information.)

How Many Employees Does Dextech Medical Have?

Dextech Medical has 1 employees, based on their latest Companies House report.

What is the current trading status of Dextech Medical (Spotlight: DEXTECH)?

As of 20/09/2026, Dextech Medical (DEXTECH) is trading at a share price of 9.900 SEK, with a previous close of 9.900 SEK. The stock has fluctuated within a day range of 9.900 SEK to 9.900 SEK, while its 52-week range spans from 5.850 SEK to 14.400 SEK.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.